News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
119 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44431)
2016 (38329)
2017 (37186)
2018 (39119)
2019 (51334)
2020 (57662)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37440)
2025 (33091)
2026 (28668)
Month
January (2434)
February (2869)
March (3030)
April (3117)
May (3356)
June (2726)
July (2287)
August (2491)
September (2814)
October (3178)
November (366)
Day
1 (41)
2 (206)
3 (119)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
Day
1
2
3
Press Releases
Progentos Therapeutics Announces First Participant Dosed in Phase 1/2a Study of PRO‑1562 for Remyelination in Multiple Sclerosis
November 3, 2026
·
2 min read
Earnings
Pfizer flat in Q3 despite 32% growth for new and acquired products
Sales of assets from Seagen and Biohaven grew in the third quarter, but it wasn’t enough for Pfizer to overcome declines across the Prevnar and COVID franchises.
November 3, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
FDA Confirms SeaStar Medical Has Fulfilled the Post-Approval Study Requirements for QUELIMMUNE® for the Treatment of Sepsis-Associated Acute Kidney Injury (AKI) in Pediatric Patients
November 3, 2026
·
10 min read
Press Releases
Milestone Pharmaceuticals to Announce Third Quarter 2026 Financial Results on November 13, 2026
November 3, 2026
·
1 min read
Press Releases
Phathom Pharmaceuticals Announces Eligible Commercially Insured Patients May Now Pay as Little as $0 for VOQUEZNA® (vonoprazan) Tablets Exclusively at BlinkRx
November 3, 2026
·
11 min read
Press Releases
Allogene Highlights Clinical Progress and Next-Generation Innovation Across Its Off-the-Shelf CAR T Platform at SITC Annual Meeting
November 3, 2026
·
5 min read
Press Releases
LENSAR® to Report Third Quarter 2026 Results on November 10th, 2026
November 3, 2026
·
1 min read
Press Releases
4DMT to Participate in Upcoming Investor Conferences - November 3, 2026
November 3, 2026
·
2 min read
Press Releases
Bolt Biotherapeutics to Participate in Upcoming Conferences - November 3, 2026
November 3, 2026
·
5 min read
Press Releases
Avalyn to Present at Upcoming Investor Conferences - November 3, 2026
November 3, 2026
·
2 min read
Previous
9 of 12
Next
